KR101777910B1 - 만성창상 치료용 조성물, 이의 제조방법 및 이를 이용한 만성창상 치료용 드레싱재 - Google Patents

만성창상 치료용 조성물, 이의 제조방법 및 이를 이용한 만성창상 치료용 드레싱재 Download PDF

Info

Publication number
KR101777910B1
KR101777910B1 KR1020150061656A KR20150061656A KR101777910B1 KR 101777910 B1 KR101777910 B1 KR 101777910B1 KR 1020150061656 A KR1020150061656 A KR 1020150061656A KR 20150061656 A KR20150061656 A KR 20150061656A KR 101777910 B1 KR101777910 B1 KR 101777910B1
Authority
KR
South Korea
Prior art keywords
cationic polymer
delete delete
growth factor
growth factors
polymer
Prior art date
Application number
KR1020150061656A
Other languages
English (en)
Korean (ko)
Other versions
KR20160129459A (ko
Inventor
김현정
박일규
조완진
최환열
강연주
Original Assignee
주식회사 제네웰
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 제네웰 filed Critical 주식회사 제네웰
Priority to KR1020150061656A priority Critical patent/KR101777910B1/ko
Priority to CN201580081275.5A priority patent/CN107708722A/zh
Priority to PCT/KR2015/004473 priority patent/WO2016175358A1/ko
Priority to JP2017556937A priority patent/JP6501913B2/ja
Publication of KR20160129459A publication Critical patent/KR20160129459A/ko
Application granted granted Critical
Publication of KR101777910B1 publication Critical patent/KR101777910B1/ko

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
KR1020150061656A 2015-04-30 2015-04-30 만성창상 치료용 조성물, 이의 제조방법 및 이를 이용한 만성창상 치료용 드레싱재 KR101777910B1 (ko)

Priority Applications (4)

Application Number Priority Date Filing Date Title
KR1020150061656A KR101777910B1 (ko) 2015-04-30 2015-04-30 만성창상 치료용 조성물, 이의 제조방법 및 이를 이용한 만성창상 치료용 드레싱재
CN201580081275.5A CN107708722A (zh) 2015-04-30 2015-05-04 慢性伤口治疗用组合物、其制备方法和利用其的慢性伤口治疗用敷料
PCT/KR2015/004473 WO2016175358A1 (ko) 2015-04-30 2015-05-04 만성창상 치료용 조성물, 이의 제조방법 및 이를 이용한 만성창상 치료용 드레싱재
JP2017556937A JP6501913B2 (ja) 2015-04-30 2015-05-04 慢性創傷治療用の組成物、その製造方法及びそれを用いた慢性創傷治療用のドレッシング材

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020150061656A KR101777910B1 (ko) 2015-04-30 2015-04-30 만성창상 치료용 조성물, 이의 제조방법 및 이를 이용한 만성창상 치료용 드레싱재

Publications (2)

Publication Number Publication Date
KR20160129459A KR20160129459A (ko) 2016-11-09
KR101777910B1 true KR101777910B1 (ko) 2017-09-13

Family

ID=57199196

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020150061656A KR101777910B1 (ko) 2015-04-30 2015-04-30 만성창상 치료용 조성물, 이의 제조방법 및 이를 이용한 만성창상 치료용 드레싱재

Country Status (4)

Country Link
JP (1) JP6501913B2 (zh)
KR (1) KR101777910B1 (zh)
CN (1) CN107708722A (zh)
WO (1) WO2016175358A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108066805B (zh) * 2016-11-17 2021-06-01 大连敏慧精益科技有限公司 一种ε-聚赖氨酸仿生抑菌膜及其制备和应用
KR20180076063A (ko) * 2016-12-27 2018-07-05 (주) 삼보 덱스트란 기반의 창상피복재 및 그 제조방법
KR102218427B1 (ko) * 2017-09-20 2021-02-22 차의과학대학교 산학협력단 단백질 약물을 포함하는 코아세르베이트 조성물 및 이를 포함하는 창상 치료제
KR102350526B1 (ko) * 2018-08-16 2022-01-17 (주)메디제이 응집성이 개선된 창상피복재 조성물의 제조 방법
KR20210081352A (ko) * 2018-10-24 2021-07-01 솜니오 글로벌 홀딩스, 엘엘씨 기능적 상처 치유 드레싱
CN113174092B (zh) * 2021-05-17 2022-10-25 西安交通大学 透明质酸-ε-聚赖氨酸盐酸盐的聚离子复合物、制备方法及应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3761816B2 (ja) 2000-02-21 2006-03-29 ダエウン ファーマシューティカル カンパニー リミテッド 上皮細胞成長因子を有効成分とする安定した組成物
JP2012226205A (ja) * 2011-04-21 2012-11-15 Olympus Imaging Corp 駆動装置およびそれを用いた画像装置
JP2013226205A (ja) * 2012-04-24 2013-11-07 Kaohsiung Medical Univ 創傷治癒用の生体材料およびその調製

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034375A (en) * 1988-08-10 1991-07-23 Institute Of Molecular Biology, Inc. Process of wound healing using PDGF and EGF
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
JP2004161684A (ja) * 2002-11-13 2004-06-10 Nitto Denko Corp 生理活性物質含有創傷治癒用フィルム製剤
JP2005152298A (ja) * 2003-11-26 2005-06-16 Techno Surg:Kk マトリックスとその製造方法
KR20080104932A (ko) * 2007-05-29 2008-12-03 금오공과대학교 산학협력단 키토산, 생분해성 고분자 및 세포성장인자를 함유하는나노섬유 부직포
CN102120033A (zh) * 2011-03-07 2011-07-13 温州医学院 促口腔额面部多种创伤修复的复合生长因子的胶原蛋白缓释载体材料及其制备方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3761816B2 (ja) 2000-02-21 2006-03-29 ダエウン ファーマシューティカル カンパニー リミテッド 上皮細胞成長因子を有効成分とする安定した組成物
JP2012226205A (ja) * 2011-04-21 2012-11-15 Olympus Imaging Corp 駆動装置およびそれを用いた画像装置
JP2013226205A (ja) * 2012-04-24 2013-11-07 Kaohsiung Medical Univ 創傷治癒用の生体材料およびその調製

Also Published As

Publication number Publication date
WO2016175358A1 (ko) 2016-11-03
JP6501913B2 (ja) 2019-04-17
KR20160129459A (ko) 2016-11-09
JP2018515478A (ja) 2018-06-14
CN107708722A (zh) 2018-02-16

Similar Documents

Publication Publication Date Title
KR101777910B1 (ko) 만성창상 치료용 조성물, 이의 제조방법 및 이를 이용한 만성창상 치료용 드레싱재
Gao et al. In situ formation of injectable hydrogels for chronic wound healing
Feng et al. Chitosan-based functional materials for skin wound repair: Mechanisms and applications
Yuan et al. A physicochemical double cross-linked multifunctional hydrogel for dynamic burn wound healing: shape adaptability, injectable self-healing property and enhanced adhesion
Kim et al. Advanced drug delivery systems and artificial skin grafts for skin wound healing
Nosrati et al. Cationic, anionic and neutral polysaccharides for skin tissue engineering and wound healing applications
Fan et al. Biomimetic hydrogels to promote wound healing
Yao et al. Recent trends on burn wound care: Hydrogel dressings and scaffolds
Graça et al. Hyaluronic acid—Based wound dressings: A review
Gruppuso et al. Polymeric wound dressings, an insight into polysaccharide-based electrospun membranes
ES2243000T3 (es) Nuevos medicamentos basados en polimeros compuestos de gelatina modificada con metacrilamina.
Chopra et al. Strategies and therapies for wound healing: a review
Lin et al. Chitosan-poloxamer-based thermosensitive hydrogels containing zinc gluconate/recombinant human epidermal growth factor benefit for antibacterial and wound healing
ES2934158T3 (es) Biomateriales de colágeno bioactivo y métodos para su fabricación
CN103159967B (zh) 一种具有自抗炎功能的胶原基海绵伤口敷料的制备方法
Shi et al. Recent progresses of collagen dressings for chronic skin wound healing
Chen et al. The role of gel wound dressings loaded with stem cells in the treatment of diabetic foot ulcers
KR101303284B1 (ko) 히알루론산과 콘드로이틴 설페이트를 함유한 수화겔 및 이의 제조방법
Zhang et al. The dual delivery of growth factors and antimicrobial peptide by PLGA/GO composite biofilms to promote skin-wound healing
Goonoo et al. Nanomaterials combination for wound healing and skin regeneration
Rajkumar et al. Chitosan-Based Biomaterial in Wound Healing: A Review
Yang et al. Effect of natural polymer materials on skin healing based on internal wound microenvironment: a review
Wang et al. A sequential therapeutic hydrogel with injectability and antibacterial activity for deep burn wounds’ cleaning and healing
EP1955705A1 (en) Wound healing agent and composition
CN111317855B (zh) 促进糖尿病溃疡创面愈合的三维复合海绵状结构体及方法

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
AMND Amendment
E90F Notification of reason for final refusal
AMND Amendment
E601 Decision to refuse application
AMND Amendment
X701 Decision to grant (after re-examination)
GRNT Written decision to grant